The effect of prolactin and apolipoprotein E gene polymorphism on cognitive functions of menopausal women;Poziom prolaktyny i polimorfizm genu apolipoproteiny E a funkcje poznawcze kobiet po menopauzie

Ginekologia Polska

Volumn 85, Issue 2, 2014, Pages 131-139

  Bojar, Iwona ^a   Raczkiewicz, Dorota ^b   Wdowiak, Artur ^c   Owoc, Alfred ^d  

^a INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^b Instytut Statystyki i Demografii   (Poland)

^c Uniwersytet   (Poland)

^d Lubuska Wyzsza Szko a Zdrowia Publicznego Zielonej Górze   (Poland)

Author keywords

Cognitive functionse; Menopause; Prolactin

Indexed keywords

APOLIPOPROTEIN E; PROLACTIN;

AGED; ARTICLE; BLOOD; COGNITIVE DEFECT; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NEUROPSYCHOLOGICAL TEST; POLAND; POSTMENOPAUSE; REPRODUCIBILITY;

AGED; APOLIPOPROTEINS E; COGNITION DISORDERS; FEMALE; HUMANS; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; NEUROPSYCHOLOGICAL TESTS; POLAND; POLYMORPHISM, GENETIC; POSTMENOPAUSE; PROLACTIN; REPRODUCIBILITY OF RESULTS;

EID: 84897513679     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: 10.17772/gp/1703     Document Type: Article

References (36)

1. Milewicz T, Krzysiek J, Rogatko I, [et al.]. Zmiany aktywnosci osi somatotropowej w trakcie szesciomiesiecznej przezskórnej podazy 17β-estradiolu wraz z doustna podaza medroksyprogesteronu u kobiet po menopauzie. Ginekol Pol. 2011, 82 (04), 254-258.
2. Norberg J, Graff C, Almkvist O, [et al.]. Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjects. Dement Geriatr Cogn Disord. 2011, 32 (2), 135-142.
3. Caselli RJ. Phenotypic differences between apolipoprotein E genetic subgroups: research and clinical implications. Alzheimers Res Ther. 2012, 4 (3), 20.
4. Mendel T, Gromadzka G. Apolipoprotein E (APOE) gene polymorphism and risk and prognosis in cerebral afmyloid angiopathy-related haemorrhage. Neurol Neurochir Pol. 2010, 44 (6), 591-597.
5. Nyholt DR, Yu CE, Visscher PM. On Jim Watson's APOE status: genetic information is hard to hide. Eur J Hum Genet. 2009, 17 (2), 147-149.
6. Scarmeas N, Stern Y, Mayeux R, [et al.]. Mediterranean diet and mild cognitive impairment. Arch Neurol. 2009, 66 (2), 216-225.
7. Scarmeas N, Luchsinger JA, Stern Y, [et al.]. Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease. Ann Neurol. 2011, 69 (2), 257-268.
8. Jiang Q, Lee CY, Mandrekar, S, [et al.]. ApoE promotes the proteolytic degradation of Abeta. Neuron. 2008, 58 (5), 681-693.
9. Bell RD, Sagare AP, Friedman AE, [et al.]. Transport pathways for clearance of human Alzheimer's amyloid betapeptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab. 2007, 27 (5), 909-918.
10. Arbones-Mainar JM, Johnson LA, Altenburg MK, Maeda N. Differential modulation of dietinduced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice. Int J Obes (Lond). 2008, 32 (10), 1595-1605.
11. Nathan BP, Barsukova AG, Shen F, [et al.]. Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology. 2004, 145 (1), 3065-3073.
12. Badowska-Kozakiewicz AM. Biologiczna rola prolaktyny. Prz Menop 2012, 4, 305-308.
13. Jarzabek-Bielecka G, Radomski D, Nowaczyk A, [et al.]. Analiza stezenia prolaktyny u dziewczat bez cech endokrynopatii z zaburzeniami miesiaczkowania i stresem w wywiadzie. Gin Prakt. 2010, 1, 46-53.
14. Tanner MJ, Hadlow NC, Wardrop R. Variation of female prolactin levels with menopausal status and phase of menstrual cycle. Aust NZJ Obstet Gynaecol. 2011, 51 (4), 321-324.
15. Morcom AM, Bullmore ET, Huppert FA, [et al.]. Memory encoding and dopamine in the aging brain: a psychopharmacological neuroimaging study. Cereb Cortex. 2010, 20 (3), 743-757.
16. Ersche KD, Roiser JP, Lucas M, [et al.]. Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. Psychopharmacology (Berl). 2011, 214 (4), 779-789.
17. Magierska J, Magierski R, Sobow T, Kloszewska I. The Polish adaptation of the Montreal Cognitive Assessment (MoCA) and preliminary results of its clinical utility in the screening for cognitive impairment. Presented at ICAD Conference Poster 2008, Chicago.
18. Gualtieri CT, Johnson LG. Reliability and validity of a computerized neurocognitive test battery, CNS Vital-Signs. Arch Clin Neuropsychol. 2006, 21 (7), 623-643.
19. Yang YG, Kim JY Park SJ, [et al.]. Apolipoprotein E genotyping by multiplex tetra-primer amplification refractory mutation system PCR in single reaction tube. J Biotech. 2007, 131 (2), 106-110.
20. Bojar I, Gustaw-Rothenberg K, Owoc A. Zaburzenia funkcji poznawczych po menopauzie-problem ciagle aktualny. Prz Menopauz. 2011, 10 (1), 68-72.
21. Bojar I, Wójcik-Fatla A, Owoc A, Lewinski A. Polymorphisms of apolipoprotein E (APOE) gene and cognitive functions of postmenopausal women, measured by battery of computer tests-Central Nervous System Vital Signs (CNS-VS). Neuro Endocrinol Lett. 2012, 33 (4), 385-392.
22. Henderson VW. Action of estrogens in the aging brain: dementia and cognitive aging. Biochim Biophys Acta. 2010, 1800 (10), 1077-1083.
23. Henderson VW. Cognition and cognitive aging. Climacteric. 2007, 10 (Suppl 2), 88-91.
24. Henderson VW. Cognitive changes after menopause: influence of estrogen. Clin Obstet Gynecol. 2008, 51 (3), 618-626.
25. LaCroix AZ, Chlebowski RT, Manson JE, [et al.], for the WHI Investigators. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA. 2011, 305 (13), 1305-1314.
26. Walker TL, Vukovic J, Koudijs MM, [et al.]. Prolactin stimulates precursor cells in the adult mouse hippocampus. PLoS One. 2012, 7 (9), e44371. doi: 10.1371/journal.pone.0044371.
27. Torner L, Karg S, Blume A, [et al.]. Prolactin prevents chronic stress-induced decrease of adult hippocampal neurogenesis and promotes neuronal fate. J Neurosci. 2009, 29 (6), 1826-1833.
28. Hyyppä MT, Liira J, Makkonen R, [et al.]. Relation between central cerebral atrophy, memory defects and prolactin secretion. Psychoneuroendocrinology. 1982, 7 (2-3), 195-200.
29. Torner L, Tinajero E, Lajud N, [et al.]. Hyperprolactinemia impairs object recognition without altering spatial learning in male rats. Behav Brain Res. 2013, 252, 32-39.
30. Henry JF, Sherwin BB. Hormones and cognitive functioning during late pregnancy and postpartum: a longitudinal study. Behav Neurosci. 2012, 126 (1), 73-85.
31. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev. 2001, 22 (6), 724-763.
32. Aalto S, Brück A, Laine M, [et al.]. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci. 2005, 25 (10), 2471-2477.
33. Lumme V, Hirvonen MM, Ilonen T, [et al.]. Cortical dopamine D2/D3 receptors and verbal memory in man. Neuroimage. 2010, 51 (2), 918-922.
34. Morcom AM, Bullmore ET, Huppert FA, [et al.]. Memory encoding and dopamine in the aging brain: a psychopharmacological neuroimaging study. Cereb Cortex. 2010, 20 (3), 743-757.
35. Bodo C, Rissman EF. New roles for estrogen receptor beta in behavior and neuroendocrinology. Front Neuroendocrinol. 2006, 27 (2), 217-232.
36. Cetinkalp S, Karadeniz M, Erdogan M,[ et al.]. Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey. J Assist Reprod Genet. 2009, 26 (1), 1-6.